Annovis Bio CEO Maria Maccecchini will present updates on the company's Phase 3 oral therapy buntanetap for Alzheimer's and Parkinson's diseases at U.S. Biotech Day 2026 and Pharma Partnering Summit 2026. She will join panels with pharma leaders and hold meetings to discuss clinical progress and upcoming milestones. These events highlight Annovis' efforts to develop treatments targeting neurotoxic proteins to slow disease progression and improve patient outcomes. Investors can expect further updates as the company advances its clinical programs.
Annovis Bio's upcoming participation in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 18:11 WIB: Out of 150 priced health-sector US stocks, 95 rose and 47 fell today. Notable movers include IOVA at USD 13.40 with a 1-day change of -9.52% and 100% sell order activity, BFLY at USD 8.25 up 5.63% with a typical hold time of 14 days, and THC at USD 254.80 down 5.10% with a typical hold time of 17 days.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
